Sectoral Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Sectoral Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-451,247	Closed	-$10.7M	–	79
2019 Q3	$10.7M	Sell	451,247 -214,466	-32%	-$6.36M	1.84%	22
2019 Q2	$20M	Sell	665,713 -20,800	-3%	-$476K	2.39%	11
2019 Q1	$15.4M	Sell	686,513 -113,099	-14%	-$2.43M	1.85%	16
2018 Q4	$14.6M	Buy	799,612 +450,900	+129%	+$7.08M	1.98%	15
2018 Q3	$6.31M	Buy	+348,712	New	+$4.13M	0.67%	47
2017 Q4	–	Sell	-278,082	Closed	-$4.06M	–	73
2017 Q3	$4.06M	Buy	278,082 +99,332	+56%	+$1.5M	0.52%	44
2017 Q2	$3.35M	Sell	178,750 -46,590	-21%	-$1.05M	0.37%	44
2017 Q1	$4.8M	Sell	225,340 -27,600	-11%	-$528K	0.56%	39
2016 Q4	$3.84M	Buy	+252,940	New	+$3.44M	0.43%	40

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sectoral Asset Management's RARX Position: Q4 2019 in Review

Sectoral Asset Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 451,247 shares — an estimated $10.7M sold.

Sectoral Asset Management first reported a position in RARX in Q4 2016 and held it in 9 quarters. The position peaked at $20M in Q2 2019. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

Sectoral Asset Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Sectoral Asset Management sold 451,247 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $10.7M.
Sectoral Asset Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 9 quarters.
Sectoral Asset Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $20M in Q2 2019.
146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Sectoral Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.